Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Ranolazine

    Client Email Product

    Ranolazine

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    56
    US DMFs Filed

    US DMFs Filed

    28
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    16
    Other Suppliers

    Other Suppliers

    40
    API REF. PRICE (USD / KG)
    93

    API Market Place

    17
    INTERMEDIATES
    13
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    54
    Europe

    Europe

    12
    Canada

    Canada

    2
    Australia

    Australia

    0

    South Africa

    South Africa

    3
    Uploaded Dossiers

    Uploaded Dossiers

    22
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    3,079.00

    Annual Reports

    758.00

    FDF Market Place

    2
    EXCIPIENTS
    162
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    3

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    25
    REF STANDARD

    EDQM

    0

    USP

    4

    JP

    0

    Other Listed Suppliers

    8
    SERVICES
    2
    left grey arrow
    right gray arrow
    • TABLET, EXTENDED RELEASE;ORAL - 1GM
    • TABLET, EXTENDED RELEASE;ORAL - 500MG
    Full View ScreenFull Screen View
    Enforcement Report - Week of November 15, 2023
    Enforcement Report - Week of November 15, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf

    FDA
    15 Nov 2023
    Share Share
    Aurobindo's Generic Ranolazine Receives Approval in the U.S.
    Aurobindo's Generic Ranolazine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209081

    FDA
    23 Dec 2022
    Share Share
    VKT Pharma's Generic Ranolazine Receives Approval in the U.S.
    VKT Pharma's Generic Ranolazine Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214035

    FDA
    19 Jan 2022
    Share Share
    Amneal`s Generic Ranolazine Receives Approval In US
    Amneal`s Generic Ranolazine Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207690

    FDA
    16 Mar 2021
    Share Share
    Graviti Pharm`s Generic Choline Ranolazine Receives Approval in US
    Graviti Pharm`s Generic Choline Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212889

    FDA
    30 Jan 2021
    Share Share
    KYE Pharmaceuticals Announces Approval of CORZYNA™ in Canada
    KYE Pharmaceuticals Announces Approval of CORZYNA™ in Canada

    https://www.newswire.ca/news-releases/kye-pharmaceuticals-announces-approval-of-corzyna-tm-in-canada-ranolazine-extended-release-tablets--857098552.html#:~:text=(%22KYE%22)%2C%20a,Canada%20after%20a%20positive%20expedited

    NEWSWIRE
    05 Jan 2021
    Share Share
    Sungen Pharma`s generic Ranolazine Receives Approval in US
    Sungen Pharma`s generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212781

    FDA
    26 Mar 2020
    Share Share
    Sunshine Lake Generic Ranolazine Receives Approval in US
    Sunshine Lake Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211865

    FDA
    26 Mar 2020
    Share Share
    Micro Lab`s Generic Ranolazine Receives Approval in US
    Micro Lab`s Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211745

    FDA
    29 Feb 2020
    Share Share
    Mankind Pharma's Generic Ranolazine Receives Approval in US
    Mankind Pharma's Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212284

    FDA
    15 Feb 2020
    Share Share
    Amerigen pharma's Generic Ranolazine Receives Approval in US
    Amerigen pharma's Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210482

    FDA
    30 Oct 2019
    Share Share
    Glenmark receives final nod from USFDA for drug to treat chronic angina
    Glenmark receives final nod from USFDA for drug to treat chronic angina

    https://www.business-standard.com/article/pti-stories/glenmark-gets-final-nod-from-usfda-for-angina-treatment-drug-119070900528_1.html

    BUSINESS STANDARD
    16 Jul 2019
    Share Share
    GLENMARK PHARMS LTD's generic RANOLAZINE Receives Approval in US
    GLENMARK PHARMS LTD's generic RANOLAZINE Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211082

    FDA
    05 Jul 2019
    Share Share
    Sciegen Pharms' Generic Ranolazine Receives Approval In US
    Sciegen Pharms' Generic Ranolazine Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211829

    04 Jun 2019
    Share Share
    Sun Pharms Generic Ranolazine Receives Approval in US
    Sun Pharms Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211707

    FDA
    31 May 2019
    Share Share
    Cipla`s Generic Ranolazine Receives Approval in US
    Cipla`s Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211291

    FDA
    31 May 2019
    Share Share
    Ajanta Pharma`s Generic Ranolazine Receives Approval in US
    Ajanta Pharma`s Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210054

    FDA
    31 May 2019
    Share Share
    Teva shares hit 19-year low after opioid settlement, analyst downgrades
    Teva shares hit 19-year low after opioid settlement, analyst downgrades

    https://www.fiercepharma.com/pharma/teva-languishing-at-19-year-low-after-opioid-settlement-analyst-downgrades

    Eric Sagonowsky FIERCE PHARMA
    31 May 2019
    Share Share
    Actavis Generic Ranolazine Receives Approval in US
    Actavis Generic Ranolazine Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208862

    FDA
    30 May 2019
    Share Share
    Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) U.S
    Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) U.S

    https://www.businesswire.com/news/home/20190528005641/en

    BUSINESSWIE
    28 May 2019
    Share Share
    Cipla's Generic Ranolazine Receives Tentative Approval in US
    Cipla's Generic Ranolazine Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211291

    FDA
    31 Oct 2018
    Share Share
    Ajanta Pharma Ltd.’s Generic Ranolazine Receives Tentative Approval in the US
    Ajanta Pharma Ltd.’s Generic Ranolazine Receives Tentative Approval in the US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210054

    FDA
    14 Jul 2018
    Share Share
    Drugmakers Cancel Price Hikes After California Law Takes Effect
    Drugmakers Cancel Price Hikes After California Law Takes Effect

    https://www.bloomberg.com/news/articles/2018-07-10/drugmakers-cancel-price-hikes-as-california-law-takes-effect

    Ben Elgin BLOOMBERG
    12 Jul 2018
    Share Share
    Aurobindo Pharma’s Generic Ranolazine Receives Approval In US
    Aurobindo Pharma’s Generic Ranolazine Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209081

    FDA
    05 Dec 2017
    Share Share
    Gilead sells phase 2 addiction drug to ex-CVT team
    Gilead sells phase 2 addiction drug to ex-CVT team

    http://www.fiercebiotech.com/deals/gilead-sells-phase-2-addiction-drug-to-ex-cvt-team

    Nick Paul Taylor FIERCE BIOTECH
    17 Feb 2017
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    DRL Ranolazine RMU

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Metrochem Ranolazine

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search